Showing results (91-100 of 126) with videos related to
Sort By:
Pageof 13
Journal of Chemical Information and Modeling|March 7, 2013
Discovery of a novel selective kappa-opioid receptor agonist using crystal structure-based virtual screeningAna Negri, Marie-Laure Rives, Michael J Caspers, et al.The EMBO Journal|August 1, 2008
Dopamine D2 receptors form higher order oligomers at physiological expression levelsWen Guo, Eneko Urizar, Michaela Kralikova, et al.Cell|November 29, 2011
Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugsMiguel Fribourg, José L Moreno, Terrell Holloway, et al.JAMA Network Open|December 2, 2022
Implementation of an Online Reporting System to Identify Unprofessional Behaviors and Mistreatment Directed at Trainees at an Academic Medical CenterI Michael Leitman, David Muller, Sophie Miller, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2015
αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombastheniaLorena Buitrago, Augusto Rendon, Yupu Liang, et al.Nature Structural & Molecular Biology|January 4, 2024
Structural basis for partial agonism in 5-HT3A receptorsKevin Felt, Madeleine Stauffer, Leslie Salas-Estrada, et al.Blood Advances|March 24, 2021
Electron microscopy shows that binding of monoclonal antibody PT25-2 primes integrin αIIbβ3 for ligand bindingDragana Nešić, Martin Bush, Aleksandar Spasic, et al.Blood Advances|January 4, 2018
αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducibleHina Zafar, Yi Shang, Jihong Li, et al.Journal of the American Chemical Society|May 19, 2016
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor ModulatorsAndrew C Kruegel, Madalee M Gassaway, Abhijeet Kapoor, et al.Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.Pageof 13